What Is Nattokinase?

Nattokinase is a fibrinolytic enzyme that originates from natto, a traditional Japanese food made by fermenting soybeans with the bacterium Bacillus subtilis. It originated from this traditional Japanese fermented food, and during the fermentation process, the bacterium produces nattokinase as a metabolic byproduct.The enzyme was first identified and isolated in the 1980s by Japanese researchers, who recognized its unique fibrinolytic properties — meaning its ability to break down fibrin, a protein involved in blood clot formation.

What makes this enzyme particularly interesting from a scientific standpoint is how it interacts with the body's own systems. To understand nattokinase, you first need to understand the problem it addresses: excess fibrin. Fibrin is a protein your body produces to form blood clots. When you cut your finger, fibrin creates a mesh that stops the bleeding — that's healthy clotting. But your body also needs to remove clots once they've done their job. This cleanup process is called fibrinolysis. As we age, the body's ability to carry out fibrinolysis naturally begins to decline, because thrombolytic enzymes are normally generated in the endothelial cells of blood vessels, and as the body ages, production of these enzymes begins to decline, making blood more prone to coagulation and fibrin accumulation in the vascular endothelium — which can eventually contribute to cardiac or cerebral events.

Nattokinase steps in with a dual approach. On one hand, it can directly hydrolyze fibrin clots and activate plasminogen to convert into plasmin, degrading fibrinogen and fibrin to dissolve thrombus; on the other hand, it can enhance the activity of the endogenous fibrinolytic system by activating tissue plasminogen activator (t-PA) while inhibiting plasminogen activator inhibitor-1 (PAI-1). This dual mechanism sets it apart from many other natural compounds. Nattokinase has a prolonged action for two reasons: it enhances the body's endogenous fibrinolytic activity and it dissolves existing thrombus. Researchers have determined that the activity of nattokinase lasts from eight to twelve hours.

How Aspirin Works as a Blood Thinner

Aspirin has been in clinical use since the late 19th century, and its role as a cardiovascular agent is well established. Aspirin is a synthetic drug first developed in the late 19th century and originally used as a pain reliever and fever reducer; it is also commonly prescribed as a blood thinner to prevent heart attacks and strokes. Specifically, aspirin functions as an antiplatelet agent — it prevents platelets in the blood from clumping together, which is one of the early stages of clot formation.

Aspirin prevents platelets from aggregating (antiplatelet), while nattokinase helps break down fibrin (fibrinolytic). Aspirin achieves this antiplatelet effect by irreversibly inhibiting an enzyme called cyclooxygenase (COX), which is responsible for producing thromboxane A2 — a molecule that promotes platelet clumping. Because the inhibition is irreversible, its effects last for the entire lifespan of the platelet, which is about 7 to 10 days. This is why even a low "baby" dose of 81 mg taken daily can have a meaningful impact on clotting dynamics over time.

Aspirin's track record in secondary cardiovascular prevention — meaning reducing the risk of another heart attack or stroke in people who have already had one — is backed by extensive, large-scale clinical trials. Randomized trials have demonstrated that aspirin lowers the risk of myocardial infarction among patients with prior cardiovascular disease as well as those with cardiovascular risk factors. However, it is worth noting that guidelines around aspirin use, particularly for primary prevention (in people who have not yet had a cardiovascular event), have shifted considerably in recent years as the risk-benefit balance has been reassessed.

Key Differences: Mechanism, Pathway, and Purpose

While both nattokinase and aspirin influence cardiovascular health and blood behavior, they operate through completely separate biological pathways — and this distinction matters enormously. Nattokinase is a fibrinolytic enzyme that supports healthy circulation by helping break down fibrin, while aspirin works by inhibiting platelet aggregation. They operate through completely different mechanisms and should not be considered interchangeable.

Think of it this way: aspirin acts earlier in the process, reducing the likelihood that platelets will start forming a clot in the first place. Nattokinase, by contrast, acts on fibrin — the structural scaffolding of an already-formed clot. Nattokinase functions independently of the body's natural anticoagulant systems. It works directly on fibrin molecules, which are the structural components of blood clots. This direct mechanism of action distinguishes nattokinase from traditional blood-thinning medications, which typically work by inhibiting clotting factors in the blood cascade.

There is also a significant difference in how thoroughly each has been studied. Aspirin's effects have been examined in massive clinical trials involving tens of thousands of patients. Nattokinase, while increasingly researched, has a smaller and more recent body of human clinical evidence. As a fibrinolytic enzyme from fermented soybean, nattokinase has been shown to be potentially beneficial for cardiovascular health, but current clinical evidence regarding nattokinase supplementation on cardiovascular risk factors varies. This doesn't mean nattokinase is ineffective — it means the evidence base is still maturing, and that context should inform how we interpret the findings.

What the Research Actually Says About Nattokinase

The science on nattokinase has grown considerably over the past two decades, and several well-designed studies point to genuine, measurable cardiovascular benefits. One of the most clinically relevant findings involves blood pressure. In a randomized, double-blind, placebo-controlled trial, net changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP) were −5.55 mmHg and −2.84 mmHg respectively after an 8-week intervention. Nattokinase supplementation resulted in a reduction in both SBP and DBP, suggesting that increased intake of nattokinase may play an important role in preventing and treating hypertension.

A 2023 systematic review and meta-analysis published in peer-reviewed literature added further support. Six studies were eligible for quantitative analysis with 546 participants, and the overall methodological quality of included studies was high.The study further supports that nattokinase can be used as an effective adjunctive therapy for hypertension. A pooled meta-analysis confirmed reductions across multiple study populations, with a meta-analysis of multiple randomized trials confirming pooled reductions of 3.45 mmHg systolic and 2.32 mmHg diastolic blood pressure.

Beyond blood pressure, researchers have explored nattokinase's impact on fibrin-related cardiovascular markers. Nattokinase has been found to have other health benefits, such as improving circulation, reducing inflammation, and supporting cardiovascular health.Importantly, no notable adverse events were reported in all studies due to intake of nattokinase — a meaningful finding when comparing its safety profile to that of pharmaceutical options. Unlike pharmaceutical thrombolytics that carry significant bleeding risk, nattokinase demonstrates fibrin specificity, meaning it preferentially breaks down fibrin clots without significantly affecting normal clotting factors.

The Risks and Side Effects of Long-Term Aspirin Use

Aspirin is a proven, well-studied medication — but like any pharmaceutical drug, it carries real risks, especially with long-term use. The most clinically significant concern is gastrointestinal bleeding. Daily aspirin use increases the risk of developing a stomach ulcer. If you already have a bleeding ulcer or gastrointestinal bleeding, taking aspirin may cause even more bleeding.In the general population, aspirin increases the risk of major GI bleeding by about 2-fold, a consistent estimate of risk observed across several studies of patients at low to average risk for aspirin-related GI complications.

This risk compounds in certain populations. Aspirin's 2-fold increase in risk in middle-aged users with no prior history of peptic ulcer substantially underestimates its actual bleeding risks in higher-risk patients — such as those with a prior history of peptic ulcer disease, advanced age, and concomitant use of NSAIDs, corticosteroids, or anticoagulants. Beyond the gastrointestinal system, aspirin also increases the risk of the serious but rare event of intracranial hemorrhage.

The Mayo Clinic puts this balance into perspective: the risk of heart attack and stroke goes up as you get older, but the risk of bleeding from aspirin goes up even more. This is precisely why physicians now carefully weigh individual risk factors before recommending daily aspirin therapy, particularly for primary prevention. For people already on aspirin by physician recommendation for secondary prevention, the absolute benefits of aspirin far outweigh the absolute risks of major bleeding events — but this calculation is individual and should only be made with a healthcare provider.

Can Nattokinase Replace Aspirin? The Honest Answer

This is the question at the heart of this article, and the honest answer deserves directness: nattokinase cannot and should not be used as a replacement for prescription or physician-recommended aspirin therapy.The research on nattokinase is promising, but it is essential to be clear about its limitations: nattokinase is not a replacement for prescribed aspirin therapy. If your doctor has prescribed aspirin for secondary cardiovascular prevention, continue taking it as directed.

There is also a critical difference in regulatory standing. Nattokinase has not been evaluated by the FDA for the treatment of any disease. It is a dietary supplement, not a drug, and it should not be positioned as a therapeutic equivalent to medications that have undergone rigorous clinical approval processes. Furthermore, nattokinase should not be combined with blood-thinning medications without physician supervision, as it may enhance anticoagulant effects. The additive effect of multiple agents affecting coagulation can increase bleeding risk unpredictably.

Real-world clinical anecdotes also illustrate the danger of substituting unproven supplements for proven medications. There are no studies showing that nattokinase works for atrial fibrillation, and physicians have seen strokes occur in patients with atrial fibrillation who were taking nattokinase but had declined a recommended stronger prescription blood thinner. The conclusion here is not that nattokinase is dangerous — the research shows it is generally well tolerated — but rather that it occupies a different category than pharmaceutical blood thinners, and conflating the two can have serious consequences.

Who May Benefit from Nattokinase as a Supplement

While nattokinase is not a replacement for prescribed medication, it does have a meaningful and well-supported role in proactive cardiovascular wellness. Nattokinase may be most appropriate as a dietary supplement for individuals who are interested in supporting healthy circulatory function as part of a proactive wellness routine. This includes adults who are not currently on prescribed blood-thinning medications and who are looking to complement a healthy lifestyle with targeted nutritional support.

The research also suggests specific population groups who may see the most benefit. The overall data suggest that the oral consumption of nattokinase supports healthy blood pressure in both sexes, in a non-Asian population, and a reduction in elevated von Willebrand factor in the female subgroup suggests a possible reduction of risk for stroke. For adults with mildly elevated blood pressure who are exploring non-pharmacological approaches, nattokinase represents one option supported by reasonable evidence.

It's also worth considering nattokinase within the broader context of a cardiovascular-supportive lifestyle. Regular exercise, a plant-rich diet, stress management, and quality sleep all contribute meaningfully to heart health. Supplements like nattokinase can complement these efforts — not substitute for them or for medications your doctor has prescribed. If you have any diagnosed cardiovascular condition, elevated blood pressure, or are currently taking any blood-thinning medications, always consult your healthcare provider before adding nattokinase or any new supplement to your routine.

Supporting Cardiovascular Wellness Naturally

For those pursuing a plant-based, natural approach to overall wellness, cardiovascular health is rarely an isolated concern. It intersects with blood pressure, inflammation, circulation, lipid balance, and even sleep quality. At QN Wellness, we believe in addressing wellness holistically, with plant-based formulations that support the body's own regulatory systems.

For example, supporting healthy blood pressure and circulation isn't just about what you take — it's also about reducing systemic inflammation, maintaining a healthy weight, and ensuring your body has the nutrients it needs to function well. Our Immune Care™ / Omega-Tree™ for Healthy Blood Pressure combination features ingredients like Garlic Extract and Flaxseed oil, both of which have documented roles in supporting cardiovascular function. Flaxseed oil provides a plant-based source of omega-3, omega-6, and omega-9 fatty acids, which are associated with healthy inflammation responses and circulatory support.

Joint mobility and musculoskeletal comfort also feed into cardiovascular health indirectly — when movement is painful, physical activity declines, and with it, the cardiovascular benefits of regular exercise. Our Plant-Glucosamine Flexi Joint™ combines Plant-based Glucosamine, MSM, and Boswellin Extract to support joint comfort and mobility, helping you stay active and keep your whole body in better shape. And for overall systemic support, Immune Care™ brings together Vitamin C, Garlic Extract, and Propolis — a trio of plant-based ingredients with long histories of use in supporting immune and cardiovascular wellness.

Quality sleep also matters more than most people realize for heart health. Poor sleep is associated with elevated blood pressure, increased inflammation, and disrupted autonomic nervous system balance — all of which affect cardiovascular risk. If nighttime restlessness or frequent bathroom visits are affecting your sleep, our Hi-Sleep™ supplement, formulated with Semen Ziziphi Spinosae, Manyprickle Acanthopanax Root, and Calcium L-aspartate, is designed to support restful, uninterrupted sleep.

Final Thoughts

Nattokinase and aspirin are genuinely interesting to compare — not because one can replace the other, but because they reveal how different the world of natural supplements is from the world of pharmaceutical drugs, even when both affect the same general domain of health. Nattokinase works through a fibrinolytic mechanism, has a growing body of research supporting its role in blood pressure management and circulatory wellness, and carries a favorable safety profile in clinical studies. Aspirin works through antiplatelet inhibition, is backed by decades of large-scale clinical trial data, and remains an important medication for many people with diagnosed cardiovascular conditions.

The key takeaway is this: if your doctor has recommended aspirin for cardiovascular prevention — particularly secondary prevention — do not stop taking it or replace it with any supplement without a direct conversation with your healthcare provider. Nattokinase has an exciting and legitimate role in proactive wellness, not as a pharmaceutical substitute. Used appropriately, as part of a plant-based, holistic approach to cardiovascular and overall health, it can be a valuable tool. The goal isn't to choose between natural and pharmaceutical — it's to use each wisely, in the context it was designed for.